Mouse mammary tumour virus (MMTV) encodes a viral superantigen (Sag) and a negative acting factor (Naf) which share parts of their coding sequence. Using 2-dimensional gel electrophoresis (2D-DIGE), we could show that at least 10 different cellular proteins were differentially expressed in Naf positive cells. Also, luciferase reporter expression was down-regulated in Naf expressing cells independent of the promoter used and further experiments suggested that this effect was due in part to a decrease in cellular growth rates. Although in Naf positive cells expression of the major sag containing transcript was strongly induced by the synthetic glucocorticoid dexamethasone, the hormone analogue neither influenced luciferase expression nor mRNA expression of selected cellular proteins identified by 2D-DIGE. Taken together, these data support the previous finding that Naf and Sag have separable activities and suggest that Naf may play a role in modulating host cell gene expression during MMTV infection. D
Introduction
The MMTV accessory factor Naf was first discovered during attempts to establish a packaging cell line for MMTV based vectors. A clone of cat kidney cells (CrFK), which are permissive for MMTV replication but free of endogenous MMTV, was stably transfected with a packaging construct containing fulllength MMTV proviral sequences under the transcriptional control of the Rous sarcoma virus (RSV) promoter and was shown to produce large amounts of MMTV proteins (Salmons et al., 1989) . Interestingly, upon stable introduction of various MMTV based retroviral vectors, expression levels of Gag proteins were considerably reduced (Salmons et al., 1990) . S1 protection assays showed that levels of correctly initiated transcripts were reduced by approximately two thirds and transcriptional run-on assays showed that the decrease of expression was due to lower transcription rates rather than reduced mRNA stability. These results suggested the existence of a trans-acting negative regulator of transcription which was subsequently termed Naf (Salmons et al., 1990) . A luciferase reporter assay system was established to allow easier analysis of the Naf effect and shows that Naf also reduces expression from heterologous viral promoters (Wintersperger et al., 1995) . MMTV also encodes for at least one other accessory factor, the viral superantigen, Sag (Acha-Orbea and Palmer, 1991; Choi et al., 1991) . Introduction of a non-sense mutation into MMTV sag sequences abolished Naf activity but further analysis of the coding requirements revealed that Naf and Sag were two different factors since Naf requires sequences from the gag gene whereas Sag does not (Salmons et al., 1990; Wintersperger et al., 1995) . Like Sag, Naf can be produced from either of the two promoters located in the 5V long terminal repeat (LTR) . To date, however, it is unclear whether one single gene product is responsible for the Naf effect or if two distinct components are necessary. In addition, it is also unclear how Naf mediates its effects on host cells.
In this study, we identified genes differentially expressed between cells expressing Naf and non-expressing cells by differential 2 dimensional gel electrophoresis (2D-DIGE). In addition, we could correlate the down-regulation of marker gene expression to cellular growth rates. Taken together, our data suggest that Naf induces differential expression which subsequently causes a reduction in growth rate.
Results

Naf induces differential expression
To measure differences in protein expression patterns after the stable introduction of the Naf expression construct, we firstly used standard 2D gel electrophoresis with only one sample per gel followed by silver staining to determine optimal pI and molecular weight range for the combination of proteins and gels we were using (Fig. 1A) . These preliminary experiments were performed in a pI range of 4 -10 and showed 30 -50 spots to be differentially expressed when comparing protein expression patterns from CrFK cells to clones COE3 and COE12 generated by stable transfection of CrFK cells with the Naf encoding construct pORFexp (data not shown). The clones do not express functional Gag, Pro, Pol and Env proteins, but have the potential to express the complete Sag.
Subsequent experiments were carried out in a pI range of 4-7 to achieve better resolution in this area. To reduce variation from experiment to experiment, 2D-DIGE was used for further investigation. This technique uses fluorescently labelled protein extracts and allows for the simultaneous analysis of up to three complex protein mixtures (Van den Fig. 1 . (A) 2D gel electrophoresis followed by silver staining of protein extracted from CK cells. Circled spots were identified as being significantly differently expressed in 2D-DIGE. Approximate protein sizes (kDa) are indicated on the left and isoelectric points (pIs) on the top. Spot numbers on the right correspond to the proteins listed in panel C. (B) Overlay image from differential 2D analysis (2D-DIGE). Equal amounts of CrFK protein extract labelled with Cy3 (displayed in green) and COE12 extract labelled with Cy5 (displayed in red) were used. The different fluorescence patterns were determined and used to create the overlay picture seen here. Spots of the same intensity for both colours/proteins appear yellow whereas protein spots over-expressed in CrFK and COE12 will appear green and red, respectively. The fluorescence pattern of the pooled standard has been omitted to reduce the complexity of the picture. The pictures in panels A and B are derived from separate gels therefore differences in protein patterns can occur. (C) Overview of the subset of gene products identified as being differentially expressed by 2D-DIGE and identified by mass spectroscopy. Shown are proteins with a mean average difference of spot volumes greater than 1.25 between Naf expressing (COE3, COE12, CNOE14) and non-expressing (CrFK, CrFKc) cell lines. Both up-regulation and down-regulation could be observed. Spot identification numbers are given as well as the average change between the two groups as fold induction (negative values indicate down-regulation), the P value calculated by Student's t test for the observed mean differences of abundance of protein in the spot between groups and the name and function of the identified protein. The given values for the relative change are averages from several clones and do not necessarily match the overlay picture spot colour, which represents a single sample pair (CrFK/COE12). The question marks indicate unknown functions. ''and'' means two proteins could be identified from one spot. ''or'' means that both proteins have similar MS patterns. Accession numbers for the identified proteins are listed. All proteins are from human origin, except 1 Sus scrofa and Bergh and Arckens, 2004) . For these experiments, proteins extracted from cells were assigned to one of two groups. Firstly, a group of cell lines not expressing Naf comprised of CrFK and CrFKc cells. CrFKc cells are a mock transfected stable population containing the empty cloning vector pcDNA3 and were included in the Naf-negative group to ensure that the differential expression could not be attributed to the process of transfection itself or the presence of sequences in the cloning vector, such as the neomycin gene. Secondly, a Naf expressing group, consisting of the clones COE3, COE12 and CNOE14, stably transfected with the Naf expressing construct and showing Naf functional activity was used. These clones show comparable levels of functional Naf as determined by downregulation of luciferase activities (data not shown). A pooled sample of all protein extracts was used as an internal standard for all gels. Differentially expressed spots were analysed as mean differences between the groups. In this way, any effects of clonal variation on differential expression could be reduced. Spots that showed a differential expression between the Naf expressing and non-expressing groups of at least 1.25-fold were selected. A t test was performed to calculate significance of the mean differences of spot abundance between the groups. The results of the 2D-DIGE can be visualised by overlay images of the different fluorescence channels of the gels (Fig.  1B) . To aid visualisation and interpretation, the channel for the standard has been excluded from the presented image so that only two of the three colours are shown. CrFK cells were stained with Cy3 (Fig. 1B , represented in green) and COE12 cells with Cy5 (Fig. 1B , represented in red). Differentially expressed spots would appear green (when over expressed in CrFK cells) or red (when over expressed in COE12 cells) in the overlay, whereas gene products expressed at similar levels would appear yellow or orange. However, it should be noted that visual analysis by the investigator only allows for rough estimates of changes. Computational analysis allowed evaluation/quantification of spots according to their mean relative changes between groups, statistical significance of the mean differences between groups and appearance ( Fig. 1C, ' 'relative change'' and ''t test'', respectively). These criteria were used for the initial selection of a set of spots which were subsequently excised and subjected to MS/MS for identification (Fig. 1C, ' 'protein'' section, see also Fig. 1A , circled spots). PA28a, RhoGDI-1 and maspin amongst others were upregulated (Fig. 1C , upper section) and proteins such as CRABP1 or the eIF5A were down-regulated (Fig. 1C , lower section). Differences are expressed as fold change and negative numbers are used to indicate down-regulation (Fig. 1C ). An induction of approximately 1.7-fold was the largest change observed between Naf expressing and non-expressing cells; levels of change between 1.26 and 1.7 were considered to be significant by us as well as by others (Alfonso et al., 2005; Lehr et al., 2005) . The functions of the identified proteins vary to a great extent (see Fig. 1C , column function).
To support the differential expression data and to assess the influence of Naf on transcriptional regulation, Northern analysis was carried out on total or mRNA extracted from CrFKc cells, the Naf clones COE3, COE12 and CNOE14 as well as 2C9 cells, a clone expressing genomic length MMTV, encoding for all MMTV proteins. We were particularly interested in changes at the transcriptional level as Naf was described as a transcriptional repressor previously and we hoped to be able to distinguish between transcriptional and post-transcritional regulation. The changes between CrFKc and the Naf clones relative to the quantity from specific transcripts for the differentially expressed genes PA28a and RhoGDI-1 were determined ( Fig. 2A, Northern) and compared to the relative changes for the individual clones obtained from 2D-GE (Figs. 2A, D) . In both cases, the average change pointed towards up-regulation of transcription for these genes, at levels comparable to the ones observed with 2D-DIGE ( Fig. 2A,  average) . In the case of PA28a, the expression patterns from 2D gels could be reproduced by Northern analysis (compare Fig. 2A , PA28a, NB and 2D sections for COE3, COE12 and CNOE14) and a clear trend for up-regulation of expression was visible (compare Fig. 2A , PA28a, averages). Induction of expression was highest in cells expressing full-length MMTV provirus ( Fig. 2A, PA28a, 2C9 ). We could not reproduce the 2D differential expression data for RhoGDI-1 on the mRNA level. Differences measured were close to 1 for the Naf clones, with the exception of CNOE14 (compare Fig. 2A , RhoGDI-1, COE3, COE12 and CNOE14). A representative Northern blot ( Naf down-regulates reporter gene expression irrespective of promoter sequence and decreases transfection efficiency A second strategy was employed to confirm the Naf effect and its association with cellular functions. A luciferase reporter system was established to screen reporter gene expression under the transcriptional control of a range of cellular and viral promoters. Cell lines, identical except for the presence of the trans-acting factor Naf, were transiently supertransfected in parallel with reporter constructs driven by the various promoters and the levels of reporter gene expression were compared (Fig.  3A) . The clones COE3 and COE12 were used to look for Naf responsive promoters in a panel of viral (cytomegalovirus, CMV; human immunodeficiency virus type 1, HIV-1; murine leukaemia virus, MLV; MMTV) and cellular promoter sequences (h-actin, BA; glucokinase, GK; carbonic anhydrase, CA; tissue factor, TF; whey acidic protein, WAP) compared to the Naf negative cells (CrFK). All constructs, regardless of whether they carried viral (Fig. 3B , lanes CMV, MLV, MTV, HIV) or cellular promoter sequences (Fig. 3B , lanes BA, GK, CA, TF) were reproducibly down-regulated in Naf expressing cells to levels that were between 20 and 40% of those obtained from CrFK cells not expressing Naf (Fig. 3B, dotted line) . In support of previously reported data (Wintersperger et al., 1995) , both COE3 and COE12 showed a reduction in luciferase activity to approximately the same levels (Fig. 3B , hatched and dotted columns, respectively).
In subsequent experiments, the Naf clones COE3 and COE12 were co-transfected with a luciferase and a CMV driven eGFP expression reporter construct. Promoter regions from HIV-1 (Fig. 4 , lanes HIV), h-actin (Fig. 4 , lanes BA) and carbonic anhydrase (Fig. 4 , lanes CA) were used to drive expression from the luciferase reporter construct, whereas eGFP expression was driven by the CMV promoter in all cases. Cells were analysed by FACS analysis and luciferase measurement in parallel. The percentage of cells transfected can be determined by FACS and hence transfection efficiency can be calculated. This can be used to standardise for the amount of transfected (i.e. reporter expressing) cells. In addition to the down-regulation of luciferase activities in the Naf expressing clones (Fig. 4A , lanes HIV, BA, CA) in comparison to CrFK cells (Fig. 4A , luciferase activity levels in CrFK cells is indicated by the dotted line), we could also observe a decrease of transfection efficiencies in Naf expressing clones COE3 and COE12 regardless of the promoter driving luciferase reporter (Fig. 4B , lanes HIV, BA, CA; transfection efficiency levels in CrFK cells are indicated by the dotted line). This decrease in transfection efficiency was highly reproducible and not accompanied by a down-regulation in mean fluorescence intensity (MFI) of the transfected cells (Fig. 4C , lanes HIV, BA, CA; mean fluorescence intensity levels in CrFK cells are indicated by the dotted line), which appears to contradict the data from the luciferase assays (Fig. 3B ). However, this observation can be explained by the fact that while in the luciferase assay all cells are included in the measurement, only the transfected cells are taken into account when measuring MFI. Taken together, these observations suggest that the downregulation of luciferase activities in Naf clones is at least in part due to less cells being transfected rather than a reduced expression level, at least for CMV driven EGFP expression.
Naf reduces growth rates
Calcium phosphate transfection precipitates are taken up by endocytosis, a process controlled by plasma membrane proteins. Although we are measuring transfection efficiency by means of expression of the eGFP gene, the results presented above suggested that the down-regulation of expression seen in Naf expressing cells may be due to the reduced uptake of DNA into the cell during transfection. To test this hypothesis, fluorescein labelled DNA was used for transfection of cells. The table shows relative changes in expression levels for PA28a and RhoGDI-1 in Naf expressing clones determined by 2D-DIGE and Northern blotting analysis. The 2D data represent the change of a single Naf clone (COE3, COE12 and CNOE14) relative to an average value for Naf negative cells (CrFKc and 3 different preparations of CrFK in the case of PA28a and 2 different preparations of CrFK cells in the case of Rho-GDI). For Northern blot analysis, total RNA from CrFKc and Naf clones was hybridised with probes specific for PA28a and RhoGDI-1. The intensities of specific bands were quantified and the mean relative differences are given here. For the dexamethasone induction factor (dex), band intensities observed in samples stimulated with dex were divided by band intensities from non-stimulated samples in Northern blotting analysis. The clonal expression patterns seen for PA28a in 2D and Northern blotting analysis follow the same pattern and indicate a trend towards up-regulation in Naf expressing cells compared to the CrFK parental cell line. The strongest upregulation was observed for 2C9, a clone containing genomic length MMTV sequences. No trend for differential expression can be seen for RhoGDI-1 expression, although the average change between Naf expressing and non-expressing cells matches the average change observed in the 2D. In addition, levels of expression of either of the two proteins were not changed significantly by the presence of dexamethasone for any clone. Results from Northern blot analysis represent the mean from 3 individual experiments, with the numbers in brackets showing the corresponding standard deviations. (B) Northern blotting analysis for differentially expressed genes PA28a and RhoGDI-1. RNA was extracted from CrFKc and COE3 cells stimulated and unstimulated with dex (À and + lanes, respectively). Equal amounts of RNA were used for Northern blots and membranes were hybridised to probes specific for PA28a (upper panel) and RhoGDI-1 (lower panel). For PA28a, a clear increase of signal intensity between CrFK and COE3 cells is visible. No significant difference is visible between dexamethasone stimulated (+) and nonstimulated (À) cells. No differences can be observed in the levels of RhoGDI-1 message produced in CrFKc and COE3 cells. As would be predicted, the sizes of transcripts are approximately 1000 (PA28a) and 2000 (RhoGDI-1) nucleotides (nt). Relative intensities (RI) of the hybridised bands are given. The blot is a representative example of a set of experiments used to determine the values for the data in panel A.
In this system, transfer of the DNA to the nucleus is not necessary for detection of the transfected molecule, hence, transfection efficiency is not dependent on cell division. However, no difference in the percentage of fluorescent cells could be observed when the Naf clones were compared to CrFKc cells, which were set at 100% (Fig. 5A , rel. TE, hatched and dotted columns, respectively). Mean fluorescence intensities (MFIs) seemed to be slightly lower, with the effect being stronger in COE12 cells (Fig. 5A rel. MFI, hatched and dotted columns, respectively); however, MFIs were generally low as the labelled DNA is difficult to detect even by FACS analysis. The results suggest that the uptake of fluorescently labelled DNA, i.e. the endocytic activity of cells, is not affected by the presence of Naf and that events occurring after the uptake of DNA into the cells are responsible for the decrease in transfection efficiencies observed in the dual reporter assays. To further investigate this, metabolic activities of the cells were determined by cellular redox enzyme activity using AlamarBlue. No difference in metabolic activity levels could be observed between CrFKc cells (Fig. 5B, light columns) and either of the Naf expressing clones COE12 (Fig. 5B , hatched columns) or CNOE14 (Fig. 5D, dotted columns) at any of the tested cell densities.
For successful expression of transfected DNA, transfer of plasmid into the nucleus is necessary and this occurs passively during the break-down of the nuclear membrane during mitosis. In turn, this means that cell division is necessary for successful transfection (Escriou et al., 2001; Zelphati et al., 1999) . Therefore, it may be that the reduced transfection efficiencies in Naf expressing cells are due to a decrease in growth rates. In addition, some of the proteins identified after 2D-DIGE and MS are linked with growth control. To test this hypothesis, we were interested to characterise the growth kinetics of Naf expressing clones. In first experiments, absolute cell numbers were plotted against time after seeding. As would be expected, after a lag phase of about 24 -48 h, the cells started to grow; however, Naf negative CrFK cells (Fig. 5C, 0) clearly grew faster than either of the Naf expressing clones COE3 (Fig. 5C , n) or CoE12 (Fig. 5C, r) . This can be quantified by calculating doubling times. We determined the doubling times of CrFKc and the Naf expressing clones COE3 and COE12 in comparison to CrFK cells and could observe a 1.5-to 2-fold increase in the time required for population doubling of COE3 and COE12, respectively (Fig. 5D ). CrFKc cells showed the same doubling times as CrFK cells, indicating that the presence of vector DNA alone did not affect the growth characteristics of the cell lines. Comparable results were obtained using two different methods for growth kinetics, namely trypan blue exclusion (Fig. 5D , hatched columns) and CASY cell counting (Fig. 5D, dotted columns) .
Sag is dexamethasone inducible in Naf clones, but the Naf effect and the associated differential expression of cellular genes are not
The activity of the major MMTV promoter, P1, can be strongly induced by dexamethasone (Gunzburg and Salmons, 1992; Hynes et al., 1983) . We evaluated Sag expression by Northern blot analysis using total RNA from Naf expressing clones. As predicted from the Naf constructs used, a message of All reporter gene assays were carried out according to the scheme shown here. Cells stably expressing the trans-acting factor of interest, e.g. Naf (1), were transiently supertransfected with a luciferase or combination of luciferase and EGFP reporter constructs. In parallel, an equal amount of the same transfection mix was used to transfect Naf negative CrFK cells (2). The experiments were analysed by luciferase assay or flow cytometry for EGFP (3). The levels observed in the Naf negative cells were set to 100% and the levels in Naf expressing cells were expressed as percentages relative to this. (B) Naf and heterologous promoters. Luciferase assays carried out on Naf clones COE3 and COE12 derived from CrFK cells by stable transfection with pORFexp. Experiments were carried out according to the scheme in panel A. CrFK cells were used to define the 100% level, which is indicated by the dotted line. The tested viral promoters (CMV, MLV, MMTV, HIV) as well as the cellular promoters (BA, GK, TF, WAP) both showed a down-regulation of luciferase activities of between 20 and 40% in both clones (COE3 hatched columns, COE12 dotted columns). The data represent the mean and standard deviations from at least three individual experiments.
approximately 1700 nucleotides was visible, also in cells containing a full-length genomic MMTV (Fig. 6A , lanes COE3, COE12, CNOE14 and 102; sag transcript). The sag message runs at the same size as the message derived from pSVorfexp (data not shown), which carries the same sequences from the 3V LTR of MMTV and was used previously for functional studies of Sag (Wintersperger et al., 1995) . In Naf expressing clones, this message was strongly inducible by dexamethasone by more than 20-fold (Fig. 6A , compare COE3À/+ and COE12À/+ lanes). The amount of full-length mRNA in Naf clones (¨4000 nt) was not enhanced (Fig. 6A , full-length) and neither was the level of an additional, uncharacterised transcript in COE3 of about 3000 nucleotides (Fig. 6A, extra) . The dex induced increase in the 1700 nt sag transcript clearly shows that the integrated Naf expression construct in the clones can respond to dex induction. Transcripts specific for the differentially expressed genes PA28a and RhoGDI-1 were not dexamethasone inducible (Fig. 2B) .
Luciferase reporter assays were carried out as described earlier (see also Fig. 3A) to test whether the Naf effect, i.e. the down-regulation of luciferase activity, was inducible by dexamethasone. Transfected cells were stimulated with dexamethasone 18 h before harvesting. The level of reduction of luciferase activity was not significantly altered in the presence of dexamethasone in COE3 or COE12 clones (Fig. 6B , compare COE3, COE12 À and + lanes) irrespective of whether a viral (e.g. RSV) promoter or a cellular (e.g. BA) promoter (Fig. 6B ) driving luciferase expression was used. These data clearly show that the Naf effect is hormone independent. Since the expression of the two analysed differentially regulated cellular genes is also dexamethasone independent, this strongly suggests that the differential expression we have observed upon transfection of the Naf expression constructs is the result of Naf expression rather than expression of hormone inducible Sag from the same construct at least for the examined proteins. However, if Sag expression was responsible for differential expression, the induction after dex stimulation should have an effect on differential expression. These results support previous findings that Naf and Sag are different factors.
Discussion
To widen our understanding of Naf function, the effects of the viral accessory factor on the host cell were studied using a 2D-DIGE proteomic profiling strategy. In this way, we hoped to identify cellular functions affected by and proteins possibly interacting with Naf. Indeed, a set of differentially expressed gene products could be identified (Fig. 1C) which represent a subset of the proteins that change in amounts between Naf expressing and non-expressing cells. It is notable that the levels of differential expression are generally quite low, with the biggest difference being an approximately 1.7-fold increase in comparison to the control group (Fig. 1C) . However, this is in fact in accordance with the previously reported Naf effect which leads to a decrease of 2.5-fold in luciferase assays (Fig.  3B) . It is likely that this effect is partly due to a reduced cell growth rate. Cell lines expressing high levels of Naf, and therefore showing higher differential expression of proteins, will have a growth disadvantage that may even lead to quiescence or cell death. This in turn makes it difficult to select for cells with high expression of Naf. In support of this hypothesis, we noticed during the production of Naf expressing clones that far more dead cells were present than in the mock transfected and control dishes and therefore that isolation of Naf positive clones was a difficult task (data not shown).
An important factor to consider when studying Naf is that the Naf expression constructs are also capable of expressing the viral superantigen Sag, therefore, any effects measured could be due to the presence of either or both factors. Therefore, it is always necessary to separate the function of these two factors when studying Naf. It was seen that a message of approximately 1700 nucleotides was strongly inducible by dex (Fig. 6A, sag) . Since this message is of a similar size to that from the Sag expression constructs pSVorfexp (Wintersperger et al., 1995) and pCSEneo (data not shown) and messages of this length have been identified in various mouse strains and have been implied to be sag messages , we believe it is reasonable to conclude that this transcript is indeed the mRNA coding for Sag. In contrast, the full-length messages present in Naf clones, of about 4000 nucleotides, were not hormone inducible (Fig. 6A, full-length) . Preliminary experiments revealed that the expression of Naf responsive cellular genes was not affected by dexamethasone treatment (Fig. 2B,  dex) . In addition, also the down-regulation of luciferase activity caused by Naf is not enhanced by the presence of dexamethasone (Fig. 6B) , clearly showing that these effects are not mediated by Sag. Because Naf was originally described as having a negative effect on transcription rates, we decided to use Northern blot analysis for further investigation since this may provide information about whether regulation of expression occurs at a transcriptional or post-transcriptional level. From the group of proteins identified by 2D-DIGE (Fig. 1) , we chose two for confirmation of differential expression by Northern blotting analysis. RhoGDI proteins are regulators of Rho GTPases that act by sequestering the enzymes in their inactive GDP-bound form in the cytosol and thereby inhibiting their activity (Olofsson, 1999) . There are three members of the RhoGDI family: RhoGDI-1 is ubiquitously expressed, whereas the RhoGDIs 2 and 3 are expressed preferentially in haematopoietic and brain cells, respectively (Olofsson, 1999) . Rho family GTPases form a family of approximately 20 members in mammals, of which RhoA, Rac and Cdc42 are the best studied. Rho proteins are involved in the remodelling of the actin cytoskeleton in response to extracellular stimuli. The over-expression of RhoGTPases, especially RhoA, is a frequent and early event in human cancer (Lin and van Golen, 2004) . In theory, the negative regulation of these pro-tumourigenic proteins by RhoGDIs should have an anti-tumourigenic effect. However, the opposite seems to be the case: RhoGDIs are overexpressed in a highly metastatic cell line (Jiang et al., 2003) , reduction of RhoGDI expression induces apoptosis (MacKeigan et al., 2003) and RhoGDIs seem to be necessary for Cdc42-mediated transformation of NIH 3T3 cells (Lin et al., 2003) . The differential over-expression of RhoGDI-1 observed in our study was rather small and could not be confirmed by Northern blot analysis. This may either be because expression differences at the transcriptional level were too small to be detected or that other factors affecting e.g. the synthesis or the longevity of the protein play a role ( Fig. 2A) . In addition, differential expression may be caused by post-transcriptional regulation and therefore not appear in the Northern blot analysis. Several studies applying proteomics methods to cancer-related topics identified RhoGDIs as differentially expressed (Jiang et al., 2003; MacKeigan et al., 2003) . We suggest that an up-regulation of RhoGDI-1 may lead to altered cell skeleton dynamics, as was observed for over-expression of Rho (Imamura et al., 1998 ). This in turn could change cellular motility and proliferation characteristics by causing changes in the downstream targets of Rho (Benitah et al., 2004) .
Proteasome activator subunit 1 (PA28a, PSME1) is a major part of the 11S (PA28) regulatory subunit of the proteasome (Rechsteiner and Hill, 2005) . It forms heteroheptameric complexes together with PA28h that can interact directly with the 20S core proteasome (Yamano et al., 2002) . The HIV-1 accessory protein Tat was reported to compete with PA28a for binding to the proteasome core (Huang et al., 2002) . PA28a and PA28h expression is inducible by IFNg and usually PA28 is expressed at high levels in professional antigen presenting cells (Macagno et al., 1999) , like B cells, which are a primary infection target for MMTV. The function of PA28a is associated with the generation of peptides that can be presented via MHC Class I molecules, although generally PA28a is not necessary for the normal processing of MHC I peptides, as shown by in vivo experiments using PA28a/PA28h double knock-outs. However, specific antigens, such as the murine tumour-associated tyrosinase-related protein 2 (TRP2) are solely dependent on PA28 for correct processing (Yamano et al., 2002) . The exact role of PA28a in MHC1-mediated Expression of a sag specific message of about 1700 nucleotides was induced strongly in COE3, COE12 and CNOE14 when dexamethasone was present (compare À and + lanes). As a control for binding of the radiolabelled probe, signals for genomic (approximately 8500 nt), env (approximately 3500 nt) and sag messages can be seen. Transcripts of about 4000 and 3000 nt visible in Naf clones (full-length and extra, respectively) are not inducible. The intensity of these signals is stronger for COE3 than for COE12 and the ''extra'' band does not appear in COE12 or CNOE14. (B) Luciferase assays were carried out according to the scheme in Fig. 3A . 18 h before harvesting cells were stimulated with dexamethasone. No change in luciferase activities could be found between cells stimulated (dotted columns) or nonstimulated (hatched columns) with dex. This could be observed in Naf clones COE3 and COE12 for viral (RSV) and cellular (BA) promoters driving luciferase expression. Values are relative to the level in CrFKc cells which is indicated by the dotted line. The data represent the mean and standard deviations from at least three experiments. presentation of antigens is not yet clear but most likely a certain subset of antigens requires the PA28 subunit of the proteasome. It may be that degradation and presentation of viral or tumour antigens like Sag could be dependent on high levels of PA28a activity. By up-regulating the levels of this factor, Naf could induce degradation of Sag, therefore inhibiting effective expression of Sag on the cell surface and subsequent oligoclonal stimulation of T cells. We could reproduce the differential expression pattern of clones observed in 2D-DIGE in Northern blots (Fig. 2) and also results from suppression subtractive hybridisation (SSH, data not shown) were supportive of these data. However, the contribution of PA28a to the observed decrease in growth rates remains unclear, although changes in proteasome activity can influence growth kinetics, e.g. via targeted degradation of cyclins (Hershko, 1996; Obaya and Sedivy, 2002) .
Other genes identified by 2D-DIGE and MS constitute interesting targets as well, for example the tumour suppressor maspin, a serpin protease inhibitor that has been shown to inhibit angiogenesis, tumour cell growth and invasion both in vitro and in vivo (Schaefer and Zhang, 2003) . Maspin may therefore contribute to the observed decrease in growth rates of Naf clones. Maspin enhances cell adhesion to the basement membrane and extracellular matrix components. CRABP-1 and the related CRABP-2 are regulators of retinoic acid (RA) signalling (Giguere, 1994) . RA is involved in the regulation of cell proliferation, differentiation and apoptosis and its changed regulation by the decrease of CRABP-1 expression in Naf clones could also contribute to reduced growth rates.
As discussed above, several of the identified proteins could be interfering with the growth behaviour of the cells. It is well known that rather subtle changes in expression levels can induce significant biological effects (Napoli et al., 2003; Choe et al., 2005) . However, it remains unclear whether these protein changes alone are responsible for the decrease of growth rates or whether other, as yet unidentified proteins that are differentially expressed contribute to the slowing of growth. These might include proteins directly involved with growth regulation, such as cyclins or MAP kinases. Also additive effects of several differentially expressed genes seem possible.
As demonstrated previously, Naf can act as a transcriptional repressor and cause the down-regulation of expression of luciferase from reporter constructs driven by different viral promoters (Salmons et al., 1990; Wintersperger et al., 1995) . In addition to measuring differential expression at the protein level using 2D-DIGE, we tested several cellular promoters in luciferase reporter assays, amongst them the transcriptional regulatory elements from the ubiquitously expressed housekeeping gene h-actin and the mammary specific whey acidic protein (WAP, Fig. 3B) , to see whether Naf could also influence expression of cellular genes at a transcriptional level. The finding that all tested promoter elements were affected to similar degrees (Fig. 3B) as well as the discovery that Naf also decreases transfection efficiencies suggested either a decrease in the capacity of cells for DNA uptake by endocytosis or the less frequent degradation and formation of nuclear membranes during mitosis. Both factors can have an influence on transfection by calcium phosphate precipitation. We examined both characteristics and found that while uptake of DNA was not affected (Fig. 5A, TE section) , growth rates were decreased for Naf clones when compared to Naf nonexpressing cell lines (Fig. 5D ). In addition, we analysed metabolic activities of Naf clones relative to parental cells and could find no difference, indicating that the overall cellular energy balance is not markedly disturbed. Reduced growth rates will reduce transfection efficiencies because less vector DNA can enter the nucleus and become expressed. As a consequence, less cells amongst the pool used for luciferase assays will express the reporter gene and since this assay does not discriminate between transfected and non-transfected cells, this will ultimately lead to lower luciferase activities, as was observed. This will not affect MFIs as this parameter only takes transfected cells into account. We propose that the change in growth rates is responsible for the down-regulation of luciferase activities and transfection efficiencies in the dual reporter assay. This will mask any promoter specific effect of Naf in luciferase assays. Additionally, the Naf-mediated effect on transcription seems to require stable expression of both Naf and the target (Salmons et al., 1990; Wintersperger et al., 1995) therefore transient supertransfection with the reporter construct might not be sufficient for transcriptional down-regulation.
Taken together, our observations strongly suggest that Naf is a factor independent from Sag that in addition to its function as a transcriptional repressor of retroviral genomes can mediate differential expression of host genes, which in turn has an effect on host cell growth kinetics. Retroviruses are known to encode accessory factors to modulate gene expression to suit their needs, like HIV Nef, which down-regulates expression of the HIV receptor CD4 (Garcia and Miller, 1991) and MHC class I molecules (Schwartz et al., 1996) . However, the exact nature and the biological relevance of Naf function itself still remain unclear. MMTV needs to adapt to different cellular surroundings during infection. Naf might only be expressed at certain times in the viral life cycle and only in certain cell types. As expression patterns vary from cell type to cell type, it will be important for evaluating Naf effects on differential expression to extend research to cells infected by MMTV in vivo especially murine mammary and B cells and this is currently being investigated.
We can only speculate upon a possible function of Naf in a biological context here but early publications concerning MMTV Sag also proposed a negative acting regulatory factor (Beutner et al., 1992) to control superantigen activity. It seems reasonable that such a regulator would share coding regions and promoter usage with Sag, as over-expression of one would probably also generate higher levels of the other, thus generating a negative feedback loop. Alternatively, Naf might be used to keep infected cells in an anti-proliferative state, to prevent early onset of MMTV-related tumourigenesis. Another possible explanation is that Naf contributes to viral latency by allowing only minimal viral genetic programmes to be carried out, similar to the way alphaherpesviruses persist (Daheshia et al., 1998) as well as inducing cellular quiescence to support latency. In addition, Naf expression could be a prerequisite for establishing endogenous copies of MMTV or indeed a relic mechanism by which MMTV previously became endogenous.
Material and methods
Vector DNA pGR102 and pORFexp have been previously described (Salmons et al., 1985; Wintersperger et al., 1995) . The plasmid pGR102 contains a full hybrid provirus sequence capable of expressing all MMTV proteins. pORFexp was derived from pGR102 by deletion of a NcoI-fragment which removes large portions of the gag and env and the complete pro and pol ORFs. pcDNA3 was purchased from Invitrogen. pMLVluc, pHIVluc, pMtv9luc and pB-actinluc have been previously described (Wintersperger et al., 1995) and contain the luciferase reporter gene sequence under the transcriptional control of murine leukaemia virus (MLV), human immunodeficiency virus (HIV), MMTV and h-actin promoter regions. Luciferase expression constructs pCMVluc, pWAPluc, pGKlucCz, pCAlucCz and pTFlucCz carry promoter sequences from cytomegalovirus (CMV), whey acidic protein (WAP), glucokinase (GK), carbonic anhydrase (CA) and tissue factor (TF), respectively. pCMVEGFP was derived from pcDNA3 by introduction of the enhanced green fluorescent protein (EGFP) gene into the multiple cloning site (Walter et al., 2000) .
Cell clones
All stable cell lines were based on Crandell feline kidney (CrFK) cells (Crandell et al., 1973) . CrFK cells are one of few cell lines permissive for MMTV infection but do not carry endogenous copies of MMTV and in addition are easily transfectable by various methods. Clones COE3 and COE12 are stable clones of CrFK cells transfected with pORFexp (Wintersperger et al., 1995) . 2C9 and CNOE14 are clones derived after stable transfection of CrFK cells with pGR102 and pORFexp, respectively. CNOE14 contains the whole viral gene cassette from pORFexp as determined by Southern blot and was shown to display Naf activity measured by the luciferase reporter system at a comparable level to Naf clones COE3 and COE12 (data not shown). CK102 and CrFKc are populations of CrFK cells stably transfected with pGR102 and the neomycin resistance gene, respectively. All cell lines were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 5% fetal calf serum. For selection, 400 Ag/ml of the neomycin derivative G418 (Life Technologies) was added to the culture medium. Dexamethasone stimulation was carried out in a final concentration of 10 À6 M for 18 h.
Transfections
Transient Cells seeded at 5 Â 10 5 cells per 6-cm dish were transfected with 3 Ag of luciferase reporter plasmid or for co-transfection with 3 Ag luciferase plasmid plus 300 ng of pCMVEGFP by calcium phosphate precipitation according to the manufacturer's instructions (GE Health Care).
Stable
CrFK cells seeded at 1 Â 10 6 cells per 10 cm dish were transfected using 10 Ag of expression plasmid and 1 Ag of pcDNA3 for selection using G418. After transfection, the cells were washed, trypsinised and replated in medium supplemented with 400 Ag/ml G418.
2D differential gel electrophoresis (2D-DIGE)
Cell pellets were lysed in 30 mM Tris -HCl, 9 M urea, 4% CHAPS (w/v), pH 8.5, using 7 Â 10 7 cells per ml lysis solution. Protein content was determined by Coomassie G-250 protein binding assay (Bradford, 1976) . Samples were then diluted in lysis puffer and labelled with CyDyes (GE Health Care, formerly Amersham Biosciences) according to the instructions of the manufacturer (8 nmol dye/mg protein). Two labelled samples (Cy3, Cy5) and a sample pool (internal standard, Cy2) were mixed and run on one gel. Classical 2D-GE was performed in accordance to existing protocols (see http://www.expasy.ch/ch2d). 25 Ag per labelled sample was applied cathodically to laboratory-made linear IPGs pH 4-7 (of 10 cm length and run on a Multiphor system (GE Health Care)) until 15 kVh was reached. The IPG strips were made according to LKB Manual (LKB 2117 Multiphor Electrophoresis System, LKB Produkter AB, Sweden, 1986, pp. 70-82) . After equilibration, strips were transferred to an SDS-PAGE gel (T = 10 -15% linear gradient, C = 2.7%) according to Laemmli (1970) for the second dimension in a Hoefer SE 600 vertical electrophoresis chamber (GE Health Care). For fluorescence detection, 2D-GE gels were scanned on a Typhoon 9400 imager and evaluated with DeCyder Software V5.02 (all GE Health Care). Protein spots differentially expressed between the two sample groups (controls/transfected cells) were looked for, using volume ratios and student's t test as selection/discrimination criteria. For protein identification of single spots by means of mass spectrometry methods, protein patterns in 2D-GE were detected by a modified silver staining according to Heukeshoven (Miller and Gemeiner, 1992) , omitting glutaraldehyde in the sensitising solution and formaldehyde in the impregnating solution. Gels were scanned with a Sharp JX-330 flatbed scanner.
Mass spectroscopy (MS)
Sample preparation
The respective spots were cut out from the gel with a scalpel, transferred to reaction vials and dehydrated with acetonitrile. In-gel protein reduction, alkylation and trypsination were performed as described previously (Zenzmaier et al., 2005) .
nano-HPLC-MS/MS protein sequencing
All nano-HPLC separations were performed on the UltiMate system from LC Packings (Amsterdam, Netherlands). The UltiMate system consists of a AHPLC pump connected to a UV detection unit, the Switchos A-column-switching device with loading pump, two 10-port valves for pre-concentration and the FAMOS A-autosampler. Eluting peptides were directly introduced into the MS and ionised via Pico Tip (New Objective, Cambridge, USA) to be further transferred online to a heated capillary of an ion trap mass spectrometer (LCQ Deca XPplus, Thermo Finnigan) as described previously (Zenzmaier et al., 2005) . Analysis of MS/MS spectra with respect to peptide identity was routinely performed by applying both the MASCOT (Perkins et al., 1999 ) (Matrix Science) and the SEQUEST (Eng et al., 1994 ) (Thermo Finnigan) search engines. A peptide was reliably identified only if the individual peptide score was !40 (Mascot) and !3 for triply charged peptides and !2.5 for double charged peptides (Sequest), respectively.
Generation of probes
Specific target gene sequences for use as probes for Northern blots were generated by RT-PCR. 5 Ag of total RNA was used as template for cDNA synthesis using Superscript II reverse transcriptase (Invitrogen), according to the manufacturer's instructions. The following primers were used for RT-PCR: FPA1 (5V-ggagccagctctcaatgaag-3V) and RPA1 (5V-cggatctccatgaccatcag-3V) for the proteasome activator subunit 1 (PA28a); FRDI1 (5V-atgagcactcggtcaactac-3V) and RRDI1 (5V-tcagtccctccagtccttct-3V) for the rho GDP dissociation inhibitor 1 (RhoGDI-1). Primers (VBC Genomic, Vienna) were designed based upon gene sequences derived from BLAST searches and PCR fragments were sequenced (VBC Genomic, Vienna) to confirm the correct sequence.
Northern blot analysis
Total RNA was prepared using the Qiagen RNeasy and QiaShredder kits and mRNA was prepared using the Amersham Quickprep Micro mRNA purification kit according to the manufacturer's instructions. 25 Ag of total RNA (1-4 Ag of mRNA) per sample was run on 1.2% agarose gels containing formaldehyde in 1Â MOPS (19.7 mM 3-(N-morpholino) propane sulphonic acid, 8 mM sodium citrate trihydrate, 1 mM EDTA) as running buffer. Gels were blotted overnight in 5Â SSC onto Amersham Hybond N+ membranes. Hybridisation was carried out at 65 -C overnight using Amersham RapidHyb hybridisation buffer. Blots were developed using FugiScreen Imaging Plates (BAS-MP 2040S, Fuji) and analysed using a Storm 860 imager (GE Health Care). For quantification of bands, ImageQuaNT software (Molecular Dynamics) was used.
Methylene blue staining
Membranes were stained in 0.04% methylene blue (Sigma) dissolved in 0.5 M sodium acetate (pH 5.5) for 15 min and then destained in distilled water. The stained membranes were scanned and bands were quantified as described for Northern blot analysis. The intensities of the bands of 18S rRNA were used to standardise intensities of bands after hybridisations.
Luciferase assays
Cell protein extracts were prepared 48 h after transfection. Protein concentration was measured using the D C protein assay according to the manufacturer's instructions (BioRad) and 20 and 10 Ag of total protein were used for the luciferase assay. A Berthold AutoLumat LB953 was used for measuring luciferase activities which were calculated as percentages relative to levels observed in CrFK or CrFKc cells.
Growth curves
To establish the assay system, cells seeded at 2 Â 10 5 in 10-cm dishes were counted after 4, 24, 48, 72 and 120 h using trypan blue exclusion. For the calculation of doubling times, cells were seeded as above, but only harvested at 72 and 120 h. 50 Al of cell suspension was mixed with an equal volume of 0.4% trypan blue solution (Sigma) and counted using haemocytometer slides (Megumed Diagnostics). In addition, a CASY Model TT (Schärfe Systems) was used for counting.
AlamarBlue metabolic assay
AlamarBlue (TREK diagnostic systems) was used for measuring metabolic activity. 1/10th volume of AlamarBlue reagent was added to cell suspensions and incubated for 6 h at 37 -C. The samples were measured using a plate reader (Genios, TECAN). Fluorescence was measured at 590 nm.
Fluorescein labelling of plasmid DNA
Plasmid DNA was labelled with fluorescein using the FluoroULS kit (FermentasMBI) according to the manufacturer's protocol. The labelled DNA was used for transfection using 1 Ag of labelled DNA and measured by FACS analysis.
Flow cytometry (FACS)
Cells were sorted using a Becton and Dickinson FACSCalibur flow cytometer. FACS analysis was performed on 10,000 events per sample. Populations to be analysed were defined by forward/side scatter dot blot cytograms. The results were analysed using the Cell Quest Pro software (BectonDickinson).
